Pakistan viral infection and healthcare challenges

Pakistan is navigating significant challenges regarding blood-borne viral infections and healthcare infrastructure. To address the hepatitis delta virus, which affects an estimated one million people in the country, the federal health ministry signed a bilateral agreement with the Chinese firm Huahui Health. This deal aims to facilitate local availability of a new drug that has completed Phase II clinical trials.

However, the broader healthcare landscape faces critical issues. Reports indicate that Pakistan carries the world's highest burden of Hepatitis C and is experiencing one of the fastest-growing HIV epidemics in the WHO Eastern Mediterranean region. These rising infection rates are attributed to systemic deficiencies, including unsafe injections, inadequate sterilization, and poorly screened blood.

Economic and structural factors further exacerbate the situation. Public health expenditure remains low at approximately 0.8 percent of the GDP. While urban centers like Karachi maintain sophisticated private medical facilities, other districts struggle with unregulated practitioners, poor sanitation, and limited access to primary healthcare.